Potential to become the best treatment for multiple myeloma in history

As a late breaking, the MAIA-study was presented at EHA 2021 by Thierry Facon, Professor of Haematology, France. In this MEDtalk Facon presents the most important data from MAIA-study. He also give an answer to the following question: Is daratumumab-lenalidomide-dexamethasone the best therapy of multiple myeloma in the history?